|Articles|May 11, 2022 (Updated: June 9, 2022)
- Pharmaceutical Executive-05-01-2022
- Volume 42
- Issue 5
Pharmaceutical Executive, May 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive May 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 4 years ago
Restoring Hope in Mental Illness Is a Collective Missionalmost 4 years ago
Upward Mobility: Optimizing Your Pharma T-Profilealmost 4 years ago
Breadth, Depth, and Enterprisealmost 4 years ago
Rising to the Taskalmost 4 years ago
Lessons Learnedalmost 4 years ago
Persistence Pays Offalmost 4 years ago
Authenticity in Actionalmost 4 years ago
Challenging Assumptionsalmost 4 years ago
Steady at the ControlsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

